Yasuhiro Shirakawa
Overview
Explore the profile of Yasuhiro Shirakawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
157
Citations
1688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mizusawa Y, Katsura Y, Shirakawa Y, Kawabe K, Shimizu A, Sawada H, et al.
Gan To Kagaku Ryoho
. 2025 Feb;
51(13):1292-1294.
PMID: 39948833
The 12th edition of the Management of Esophageal Cancer guidelines recommends a regimen that includes immune checkpoint inhibitor(ICI)therapy as the primary treatment for Stage ⅣB esophageal cancer, which increases the...
2.
Sonoi M, Shirakawa Y, Sonoi N, Noma K, Tanabe S, Maeda N, et al.
Asian Pac J Cancer Prev
. 2025 Jan;
26(1):263-267.
PMID: 39874009
Objective: This study aimed to clarify whether nutritional status at admission affects enteral nutrition weaning 6 months after surgery in patients with esophageal cancer. Methods: This was a retrospective study...
3.
Yamanaka-Kohno R, Shirakawa Y, Inoue-Minakuchi M, Yokoi A, Noma K, Tanabe S, et al.
Nutrients
. 2025 Jan;
16(24.
PMID: 39771004
A high prognostic nutritional index (PNI) is associated with good prognosis in patients with esophageal cancer. However, nutritional status often decreases during neoadjuvant therapy. Functional tooth units (FTUs) provide an...
4.
Nishimura S, Noma K, Kawasaki K, Hashimoto M, Kato T, Maeda N, et al.
Surg Case Rep
. 2024 Nov;
10(1):252.
PMID: 39489816
Background: Gastro-tracheal fistula is a rare but serious complication after esophageal surgery, often requiring long-term treatment and invasive procedures. Gastro-tracheal fistula usually occurs through the posterior mediastinal route and rarely...
5.
Moriuchi T, Katsura Y, Shirakawa Y, Uehara A, Matsubara K, Ishida M, et al.
Surg Case Rep
. 2024 Oct;
10(1):236.
PMID: 39412618
Background: Gastric conduit obstruction (GCO) is a known complication after esophagectomy. Laparoscopic revision surgery for GCO is relatively rare, with limited reports in the literature. Here, we report a case...
6.
Yamanaka-Kohno R, Shirakawa Y, Yokoi A, Maeda N, Tanabe S, Noma K, et al.
Sci Rep
. 2024 Oct;
14(1):23886.
PMID: 39396079
Tongue pressure (TP) decreases significantly after esophagectomy in esophageal cancer patients (ECPs). Meanwhile, 2 weeks of gum-chewing training (GCT) significantly increased TP in healthy university students. We examined whether perioperative...
7.
Mizusawa Y, Sawada H, Idani H, Nakano K, Yoshimitsu M, Shimizu A, et al.
Am J Case Rep
. 2024 Sep;
25:e944094.
PMID: 39342423
BACKGROUND Gas in the portal venous system, or hepatic portal venous gas, is a rare occurrence associated with ischemic colitis, inflammatory bowel disease, or any cause of bowel perforation, including...
8.
Moriuchi T, Shirakawa Y, Katsura Y, Ishida M, Choda Y
Cureus
. 2024 Sep;
16(8):e67626.
PMID: 39310449
Patients with esophageal cancer who have severe complications such as diabetes sometimes require two-stage surgery. Herein, we describe two cases of gastric emphysema that were treated at our facility after...
9.
Moriwake K, Noma K, Kawasaki K, Matsumoto T, Hashimoto M, Kato T, et al.
Surg Case Rep
. 2024 May;
10(1):128.
PMID: 38775882
Background: Pancreatoduodenectomy and subtotal esophagectomy are widely considered the most invasive and difficult surgical procedures in gastrointestinal surgery. Subtotal esophagectomy after pancreatoduodenectomy is expected to be extremely difficult due to...
10.
Kobayashi T, Noma K, Nishimura S, Kato T, Nishiwaki N, Ohara T, et al.
Mol Cancer Ther
. 2024 Apr;
23(7):1031-1042.
PMID: 38638034
Esophageal cancer remains a highly aggressive malignancy with a poor prognosis, despite ongoing advancements in treatments such as immunotherapy. The tumor microenvironment, particularly cancer-associated fibroblasts (CAF), plays a crucial role...